RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

Either way from current prices the potential reward v. speculative risk is outstanding, IMO.

A scenario where they get a significant cash payment upfront to acquire the KRM-II-81 program with milestone payments could be ideal if they intend to list on a higher exchange where they can obtain institutional investment support and use the funds to further the other drug development programs, while hopefully the KRM-II-81 successfully hits milestones in the human clinicals that will then continue to add enormous value in subsequent quarters.

IF the tier 3 NIH preclinicals are successful, my opinion is a development deal is a slam dunk and the company has no business hanging out on the OTC exchange with other promising development programs in the works.

Yet here we are speculating while the company is radio silent with no 10-k filing, yet gets a cash infusion from BOD member?. Feels like a storm is brewing, just dont know if it will wipe us out or be electric and send this to nickels and dimes... OTC casino at the finest... Good luck to us all.